These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11959423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K, Onodera O, Takano H, Tsuji S.
    Neuroreport; 2001 Oct 29; 12(15):3357-64. PubMed ID: 11711886
    [Abstract] [Full Text] [Related]

  • 3. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.
    Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H.
    Neuroreport; 2002 Dec 03; 13(17):2359-64. PubMed ID: 12488827
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.
    Suzuki Y, Nakayama K, Hashimoto N, Yazawa I.
    FEBS J; 2010 Dec 03; 277(23):4873-87. PubMed ID: 20977674
    [Abstract] [Full Text] [Related]

  • 6. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
    Suzuki Y, Jin C, Yazawa I.
    Neurosci Lett; 2013 Sep 27; 552():156-61. PubMed ID: 23933208
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis.
    Sato A, Shimohata T, Koide R, Takano H, Sato T, Oyake M, Igarashi S, Tanaka K, Inuzuka T, Nawa H, Tsuji S.
    Hum Mol Genet; 1999 Jun 27; 8(6):997-1006. PubMed ID: 10332031
    [Abstract] [Full Text] [Related]

  • 8. Time course of polyglutamine aggregate body formation and cell death: enhanced growth in nucleus and an interval for cell death.
    Toyoshima I, Sugawara M, Kato K, Wada C, Shimohata T, Koide R, Onodera O, Tsuji S.
    J Neurosci Res; 2002 May 15; 68(4):442-8. PubMed ID: 11992470
    [Abstract] [Full Text] [Related]

  • 9. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K.
    Neurosci Lett; 2008 Jan 24; 431(1):45-50. PubMed ID: 18078716
    [Abstract] [Full Text] [Related]

  • 10. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
    Yamada M, Shimohata M, Sato T, Tsuji S, Takahashi H.
    Neuropathology; 2006 Aug 24; 26(4):346-51. PubMed ID: 16961072
    [Abstract] [Full Text] [Related]

  • 11. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
    Yamada M, Tan CF, Inenaga C, Tsuji S, Takahashi H.
    Neuropathol Appl Neurobiol; 2004 Dec 24; 30(6):665-75. PubMed ID: 15541006
    [Abstract] [Full Text] [Related]

  • 12. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease.
    Hoffner G, Kahlem P, Djian P.
    J Cell Sci; 2002 Mar 01; 115(Pt 5):941-8. PubMed ID: 11870213
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy.
    Miyata R, Hayashi M, Tanuma N, Shioda K, Fukatsu R, Mizutani S.
    J Neurol Sci; 2008 Jan 15; 264(1-2):133-9. PubMed ID: 17949751
    [Abstract] [Full Text] [Related]

  • 14. Genotype-phenotype correlation in CAG-repeat diseases.
    Yamada M, Tsuji S, Takahashi H.
    Neuropathology; 2002 Dec 15; 22(4):317-22. PubMed ID: 12564773
    [Abstract] [Full Text] [Related]

  • 15. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
    Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S, Kimura T, Koide R, Nozaki K, Sano Y, Ishiguro H, Sakoe K, Ooshima T, Sato A, Ikeuchi T, Oyake M, Sato T, Aoyagi Y, Hozumi I, Nagatsu T, Takiyama Y, Nishizawa M, Goto J, Kanazawa I, Davidson I, Tanese N, Takahashi H, Tsuji S.
    Nat Genet; 2000 Sep 15; 26(1):29-36. PubMed ID: 10973244
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions.
    Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F, Nukina N.
    J Neurochem; 2004 Oct 15; 91(1):57-68. PubMed ID: 15379887
    [Abstract] [Full Text] [Related]

  • 17. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice.
    Sato T, Miura M, Yamada M, Yoshida T, Wood JD, Yazawa I, Masuda M, Suzuki T, Shin RM, Yau HJ, Liu FC, Shimohata T, Onodera O, Ross CA, Katsuki M, Takahashi H, Kano M, Aosaki T, Tsuji S.
    Hum Mol Genet; 2009 Feb 15; 18(4):723-36. PubMed ID: 19039037
    [Abstract] [Full Text] [Related]

  • 18. The Expanding Clinical Universe of Polyglutamine Disease.
    Huang S, Zhu S, Li XJ, Li S.
    Neuroscientist; 2019 Oct 15; 25(5):512-520. PubMed ID: 30614396
    [Abstract] [Full Text] [Related]

  • 19. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins.
    Mitsui K, Nakayama H, Akagi T, Nekooki M, Ohtawa K, Takio K, Hashikawa T, Nukina N.
    J Neurosci; 2002 Nov 01; 22(21):9267-77. PubMed ID: 12417652
    [Abstract] [Full Text] [Related]

  • 20. [Polyglutamine diseases: a pathologic view].
    Yamada M.
    Rinsho Shinkeigaku; 2003 Nov 01; 43(11):903-5. PubMed ID: 15152499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.